{"id":39513,"date":"2026-08-03T13:46:54","date_gmt":"2026-08-03T11:46:54","guid":{"rendered":"https:\/\/ggba.swiss\/molesense-and-impli-selected-for-the-sprind-challenge-on-continuous-hormone-monitoring\/"},"modified":"2026-08-03T13:48:56","modified_gmt":"2026-08-03T11:48:56","slug":"molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/","title":{"rendered":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge sur le suivi hormonal en continu"},"content":{"rendered":"\n<p>Deux start-ups \u00e9tablies sur le campus des sciences de la vie <a href=\"https:\/\/www.biopole.ch\/\">Biop\u00f4le<\/a> \u00e0 Lausanne, <a href=\"https:\/\/www.molesense.ch\/\">MoleSense<\/a> et <a href=\"https:\/\/www.impli.co\/\">Impli<\/a>, ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es par l&rsquo;agence f\u00e9d\u00e9rale allemande pour l&rsquo;innovation de rupture (<a href=\"https:\/\/www.sprind.org\/en\/\">SPRIN-D<\/a>) dans le cadre de son Challenge consacr\u00e9 au suivi hormonal en continu. Le soutien comprend un financement pouvant atteindre EUR 1,5 million lors de la premi\u00e8re \u00e9tape.<\/p>\n\n\n\n<p>Les hormones r\u00e9gissent des processus allant du m\u00e9tabolisme et de la fonction immunitaire \u00e0 la cognition et \u00e0 la reproduction, mais elles restent mesur\u00e9es par des relev\u00e9s isol\u00e9s, \u00e0 un instant donn\u00e9. Les femmes sont particuli\u00e8rement concern\u00e9es, leurs syst\u00e8mes hormonaux pr\u00e9sentant la plus grande variabilit\u00e9 et ayant longtemps \u00e9t\u00e9 sous-repr\u00e9sent\u00e9s dans la recherche, ce qui contribue \u00e0 ce que des affections telles que l&rsquo;endom\u00e9triose, le syndrome des ovaires polykystiques ou les maladies cardiovasculaires hormono-d\u00e9pendantes soient d\u00e9tect\u00e9es tardivement ou mal comprises.<\/p>\n\n\n\n<p>Le Challenge demande aux \u00e9quipes de capter au moins quatre hormones, parmi lesquelles les \u0153strog\u00e8nes, la progest\u00e9rone, la LH, la FSH, le cortisol, la testost\u00e9rone ou les hormones thyro\u00efdiennes, sur au moins sept jours cons\u00e9cutifs, directement dans une matrice biologique telle que le liquide interstitiel, la sueur ou la salive. En parall\u00e8le, un pool de donn\u00e9es de r\u00e9f\u00e9rence partag\u00e9 est constitu\u00e9, con\u00e7u comme la premi\u00e8re collecte standardis\u00e9e de donn\u00e9es hormonales continues \u00e0 travers les populations, les phases de vie et les \u00e9tats de sant\u00e9.<\/p>\n\n\n\n<p>MoleSense d\u00e9veloppe une plateforme \u00ab wear and forget \u00bb combinant une extraction de sueur \u00e0 la demande \u00e0 tr\u00e8s faible consommation et une nanobiod\u00e9tection multi-hormonale \u00e0 base d&rsquo;aptam\u00e8res ; elle a re\u00e7u un contrat de recherche et d\u00e9veloppement pr\u00e9commercial de EUR 1,5 million pour mesurer quatre hormones dans les douze mois. Impli, qui op\u00e8re depuis Londres et Lausanne avec une propri\u00e9t\u00e9 intellectuelle issue d&rsquo;Imperial College London, d\u00e9veloppe un dispositif peu invasif \u00e0 micro-aiguilles qui suit simultan\u00e9ment un panel d&rsquo;hormones reproductives et m\u00e9taboliques sur plusieurs jours de port.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MoleSense et Impli, toutes deux \u00e9tablies au Biop\u00f4le \u00e0 Lausanne, ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es par l&rsquo;agence f\u00e9d\u00e9rale allemande pour l&rsquo;innovation de rupture afin de d\u00e9velopper des biocapteurs capables de mesurer en continu au moins quatre hormones sur sept jours.<\/p>\n","protected":false},"author":6,"featured_media":39510,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1180,1148,1188,1142,1243,1168],"class_list":["post-39513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-digital-health-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-rd-fr-2","tag-sensors-fr-2","tag-technology-park-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge<\/title>\n<meta name=\"description\" content=\"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge\" \/>\n<meta property=\"og:description\" content=\"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-03T11:46:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-03T11:48:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge sur le suivi hormonal en continu\",\"datePublished\":\"2026-08-03T11:46:54+00:00\",\"dateModified\":\"2026-08-03T11:48:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\"},\"wordCount\":360,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg\",\"keywords\":[\"Digital Health\",\"Financing\",\"Healthcare\",\"R&amp;D\",\"Sensors\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\",\"name\":\"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg\",\"datePublished\":\"2026-08-03T11:46:54+00:00\",\"dateModified\":\"2026-08-03T11:48:56+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Les \u00e9quipes de MoleSense et d'Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu. | \u00a9 SPRIN-D\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge sur le suivi hormonal en continu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge","description":"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/","og_locale":"fr_FR","og_type":"article","og_title":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge","og_description":"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.","og_url":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-08-03T11:46:54+00:00","article_modified_time":"2026-08-03T11:48:56+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge sur le suivi hormonal en continu","datePublished":"2026-08-03T11:46:54+00:00","dateModified":"2026-08-03T11:48:56+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/"},"wordCount":360,"image":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg","keywords":["Digital Health","Financing","Healthcare","R&amp;D","Sensors","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/","url":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/","name":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg","datePublished":"2026-08-03T11:46:54+00:00","dateModified":"2026-08-03T11:48:56+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Deux start-ups \u00e9tablies au Biop\u00f4le ont \u00e9t\u00e9 s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/08\/MolesenseImpli-1180x811-1.jpg","width":1180,"height":811,"caption":"Les \u00e9quipes de MoleSense et d'Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge consacr\u00e9 au suivi hormonal en continu. | \u00a9 SPRIN-D"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/molesense-et-impli-selectionnees-pour-le-sprind-challenge-sur-le-suivi-hormonal-en-continu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"MoleSense et Impli s\u00e9lectionn\u00e9es pour le SPRIND Challenge sur le suivi hormonal en continu"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=39513"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39513\/revisions"}],"predecessor-version":[{"id":39515,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39513\/revisions\/39515"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/39510"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=39513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=39513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=39513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}